低FODMAP饮食可减轻治疗后仍有症状的乳糜泻患者的症状——一项随机对照试验
该随机对照试验于2018至2019年纳入70例活检证实的乳糜泻成人患者,入组者为无麸质饮食至少12个月且血清学和组织学缓解但仍有持续胃肠道症状(GSRS-IBS评分≥30)者。患者随机接受低FODMAP-无麸质饮食(干预组34例)或常规无麸质饮食(对照组36例)。干预组GSRS-IBS总分较对照组显著降低,第1周平均差-8.2(95%CI -11.5至-5.0),第4周-10.8(95%CI -14.8至-6.8),乳糜泻症状指数第4周也显著降低(平均差-5.8,95%CI -9.6至-2.0)。
要点
- 短期适度低FODMAP饮食可显著降低治疗后仍有症状的乳糜泻患者的GSRS-IBS总分。
- 疼痛、腹胀、腹泻和饱腹感维度评分显著降低,便秘维度无显著差异(P交互=0.43)。
- 第4周乳糜泻症状指数干预组较对照组显著降低,平均差-5.8(95%CI -9.6至-2.0)。
核心结论
- 短期适度低FODMAP饮食显著减轻乳糜泻患者的胃肠道症状并改善乳糜泻特异性健康,应考虑用于乳糜泻持续症状的管理。
研究设计与样本
- 随机对照试验,2018至2019年纳入70例活检证实的乳糜泻成人患者。
- 纳入标准为GSRS-IBS版评分≥30定义的持续胃肠道症状、无麸质饮食依从≥12个月、血清学和组织学缓解。
- 随机分为低FODMAP-无麸质饮食(干预组34例)或常规无麸质饮食(对照组36例)。
主要发现
- GSRS-IBS总分随时间变化两组间差异显著(P交互<0.001),第1周干预组较对照组平均差-8.2(95%CI -11.5至-5.0),持续至第4周平均差-10.8(95%CI -14.8至-6.8)。
- 疼痛、腹胀、腹泻和饱腹感维度评分显著降低(P交互≤0.04),便秘维度无显著差异(P交互=0.43)。
- 干预期间FODMAP摄入量为适度低水平(均值8.1 g/d;95%CI 6.7-9.3 g/d)。
- 第4周乳糜泻症状指数干预组较对照组显著降低(平均差-5.8;95%CI -9.6至-2.0)。
临床怎么用
- 作者认为,短期适度低FODMAP饮食应考虑用于乳糜泻持续症状的管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: A gluten-free diet usually leads to mucosal remission in celiac disease, but persistent symptoms are common. A low fermentable oligo-, di-, monosaccharides and polyols (FODMAP) diet is an established treatment for irritable bowel syndrome (IBS). We have assessed the efficacy of a moderately low FODMAP diet on persistent symptoms in treated celiac patients. METHODS: A randomized controlled trial was performed from 2018 to 2019 in 70 adults with biopsy-proven celiac disease. Inclusion criteria were as follows: persistent gastrointestinal symptoms defined by a Gastrointestinal Symptom Rating Scale (GSRS)-IBS version score of 30 or higher, gluten-free diet adherence for 12 months or longer, and serologic and mucosal remission. Participants were randomized to a low FODMAP-gluten-free diet (intervention) or usual gluten-free diet (control). The GSRS-IBS score was recorded at baseline and at weeks 1 to 4, and the Celiac Symptom Index at baseline and at week 4. Statistics included marginal models for repeated data and analyses of covariance. RESULTS: We included 34 participants in the intervention group and 36 in the control group. Time development of GSRS-IBS total scores differed significantly between the groups (Pinteraction < .001), evident after 1 week (mean difference in intervention vs control, -8.2; 95% CI, -11.5 to -5.0) and persisting through week 4 (mean difference in intervention vs control, -10.8; 95% CI, -14.8 to -6.8). Moreover, significantly lower scores were found for the dimensions of pain, bloating, diarrhea, and satiety (Pinteraction ≤ .04), but not constipation (Pinteraction = .43). FODMAP intake during the intervention was moderately low (mean, 8.1 g/d; 95% CI, 6.7-9.3 g/d). The Celiac Symptom Index was significantly lower in the intervention group at week 4 (mean difference, -5.8; 95% CI, -9.6 to -2.0). CONCLUSIONS: A short-term moderately low FODMAP diet significantly reduced gastrointestinal symptoms and increased celiac disease-specific health, and should be considered for the management of persistent symptoms in celiac disease. CLINICALTRIALS: gov: NCT03678935.
引用
- van Megen F, Skodje GI, Lergenmuller S, et al. A Low FODMAP Diet Reduces Symptoms in Treated Celiac Patients With Ongoing Symptoms-A Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2022. PMID: 35051648. doi:10.1016/j.cgh.2022.01.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。